Correlation Between GlaxoSmithKline PLC and Songcheng Performance

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Songcheng Performance at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Songcheng Performance into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Songcheng Performance Develop, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Songcheng Performance and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Songcheng Performance. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Songcheng Performance.

Diversification Opportunities for GlaxoSmithKline PLC and Songcheng Performance

-0.77
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and Songcheng is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Songcheng Performance Develop in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Songcheng Performance and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Songcheng Performance. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Songcheng Performance has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Songcheng Performance go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Songcheng Performance

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Songcheng Performance. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 2.17 times less risky than Songcheng Performance. The stock trades about -0.12 of its potential returns per unit of risk. The Songcheng Performance Develop is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  1,009  in Songcheng Performance Develop on August 29, 2024 and sell it today you would lose (89.00) from holding Songcheng Performance Develop or give up 8.82% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy96.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Songcheng Performance Develop

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Songcheng Performance 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Songcheng Performance Develop are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Songcheng Performance sustained solid returns over the last few months and may actually be approaching a breakup point.

GlaxoSmithKline PLC and Songcheng Performance Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Songcheng Performance

The main advantage of trading using opposite GlaxoSmithKline PLC and Songcheng Performance positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Songcheng Performance can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Songcheng Performance will offset losses from the drop in Songcheng Performance's long position.
The idea behind GlaxoSmithKline PLC ADR and Songcheng Performance Develop pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance